Investigation of endogenous antigen processing by delivery of an intact protein into cells
- PMID: 18406420
- DOI: 10.1016/j.jim.2008.02.017
Investigation of endogenous antigen processing by delivery of an intact protein into cells
Abstract
Investigation of MHC class I endogenous antigen processing and presentation is important for understanding non-self immune recognition, vaccine design, immune evasion by pathogens and tumours, and elucidation of the mechanisms of certain auto-immune diseases. To study the MHC class I antigen-processing pathway, the protein antigen of interest has to be expressed inside the cells. To express a desired protein antigen, delivery of protein coding genes into the cell using transfection or infection by a virus carrying the gene of the antigen is a popular method. But there is no satisfactory method using the intact protein as antigen directly for investigation of MHC antigen processing and presentation that can give a quantitative result for the efficiency of antigen processing. Here we describe a novel method to deliver protein antigen directly into the cytosol of cells for quantitative analysis of the efficiency of antigen processing. Adherent mouse fibroblasts, mouse lymphoma cell line RMA, spleen cells and dendritic cells were permeabilized with streptolysin O, and chicken ovalbumin (OVA), a model protein antigen, was successfully introduced into the cells. Mouse fibroblast and RMA cells were able to properly process OVA protein, and OVA-derived peptide OVA(258-265) (or SIINFEKL) was successfully presented via the MHC class I molecule (K(b)) to SIINFEKL-K(b)-specific T cell hybridoma B3Z. As expected, delivery of OVA protein into RMA-S, a cell line with a deficiency in MHC class I antigen processing due to a TAP defect, failed to present the SIINFEKL epitope to B3Z.
Similar articles
-
Major histocompatibility complex class I presentation of ovalbumin peptide 257-264 from exogenous sources: protein context influences the degree of TAP-independent presentation.Eur J Immunol. 1996 Nov;26(11):2790-9. doi: 10.1002/eji.1830261135. Eur J Immunol. 1996. PMID: 8921970
-
Mouse Schwann cells activate MHC class I and II restricted T-cell responses, but require external peptide processing for MHC class II presentation.Neurobiol Dis. 2010 Feb;37(2):483-90. doi: 10.1016/j.nbd.2009.11.006. Epub 2009 Nov 13. Neurobiol Dis. 2010. PMID: 19914379
-
Corticosterone impairs MHC class I antigen presentation by dendritic cells via reduction of peptide generation.J Neuroimmunol. 2005 Mar;160(1-2):48-60. doi: 10.1016/j.jneuroim.2004.10.024. Epub 2004 Dec 23. J Neuroimmunol. 2005. PMID: 15710457
-
Bacterial antigen delivery systems: phagocytic processing of bacterial antigens for MHC-I and MHC-II presentation to T cells.Behring Inst Mitt. 1997 Feb;(98):197-211. Behring Inst Mitt. 1997. PMID: 9382741 Review.
-
Antigen processing and presentation: evolution from a bird's eye view.Mol Immunol. 2013 Sep;55(2):159-61. doi: 10.1016/j.molimm.2012.10.030. Epub 2012 Nov 22. Mol Immunol. 2013. PMID: 23182425 Free PMC article. Review.
Cited by
-
Radio Signals from Live Cells: The Coming of Age of In-Cell Solution NMR.Chem Rev. 2022 May 25;122(10):9267-9306. doi: 10.1021/acs.chemrev.1c00790. Epub 2022 Jan 21. Chem Rev. 2022. PMID: 35061391 Free PMC article. Review.
-
Cell-penetrating peptide (CPP)-conjugated proteins is an efficient tool for manipulation of human mesenchymal stromal cells.Sci Rep. 2014 Mar 14;4:4378. doi: 10.1038/srep04378. Sci Rep. 2014. PMID: 24625570 Free PMC article.
-
Intracellular Delivery by Membrane Disruption: Mechanisms, Strategies, and Concepts.Chem Rev. 2018 Aug 22;118(16):7409-7531. doi: 10.1021/acs.chemrev.7b00678. Epub 2018 Jul 27. Chem Rev. 2018. PMID: 30052023 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous